Virtu Financial LLC Prothena Corp Public LTD CO Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$25.16 - $60.63 $164,118 - $395,489	6,523 New	6,523 $395,000
Q3 2021 Nov 12, 2021	SELL	$48.2 - $78.89 $538,586 - $881,516	-11,174 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$21.63 - $57.65 $241,693 - $644,181	11,174 New	11,174 $574,000
Q4 2017 Feb 09, 2018	SELL	$35.44 - $63.76 $193,537 - $348,193	-5,461 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$53.83 - $67.75 $293,965 - $369,982	5,461	5,461 $354,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.